Gastric antral vascular ectasia (gave) – case report
Abstract
Background: Gastric antral vascular ectasia (GAVE), or »watermelon stomach« is a rare but important cause of gastrointestinal blood loss and anaemia, and has characteristic endoscopic and histological features. The pathogenesis of this condition remains unclear. The goal in treating a patient with gastric antral vascular ectasia should be the complete elimination of transfusion requirements. Various medical, surgical and endoscopic therapeutic modalities have been attempted with variable success. Currently available evidence favours endoscopic therapy using argon plasma coagulation or Nd: YAG laser.
Patients and methods: A case of 77-year-old women with gastric antral vascular ectasia is presented who was transfusion dependent due to recurrent anaemia despite iron supplements. She was successfully treated with argon plasma coagulation (APC). Two years after treatment she didn’t have anaemia and no need for transfusion.
Conclusions: It is widely belived that GAVE is under-recognized and is most often misinterpreted as antral gastritis. Although rare, it is an important cause of occult upper gastrointestinal bleeding, particularly in elderly women.
Downloads
References
Jabbari M, Cherry R, Lough JO, Daly DS, Kinnear DG, Goresky CA. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology 1984; 87: 1165–70.
Calam J, Walker RJ. Antral vascular lesion, achlorhydria and chronic blood los: response to steroids. Dig Dis Sci 1980; 25: 236–9.
Tsai HH, Smith J, Danesh BJ. Successful control of bleeding from gastric antral vascular ectasia (watermelon stomach) by laser photocoagulation. Gut 1991; 32: 93–4.
Abedi M, Haber GB. Watermelon stomach. Gastroenterologist 1997; 5: 179–84.
Gostout CJ, Viggiano TR, Ahlquist DA, Wang KK, Larson MV, Balm R. The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol 1992; 15: 256–63.
Disdier P, Schleinitz N, Perreard M, Monges D, Swiader L, Gerolami A, et al. Dramatic improvment of watermelon stomach with alpha-interferon. Am J Gastroenterol 1995; 90: 1009–10.
Moss SF, Ghosh P, Thomas DM, Jackson JE, Calam J. Gastric antral vascular ectasia; Maintenance treatment with oestrogen-progesteron. Gut 1992; 33: 715–7.
Bowmick BK. Watermelon stomach treated with oral corticosteroid. J R Soc Med 1993; 86: 52.
McCormick PA, Ooi H, Crosbie O. Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut 1998; 42: 750–2.
Bjorkman DJ, Bauchi KN. Endoscopic laser therapy of the watermelon stomach. Laser Surg Med 1992; 12: 478–81.
Binmoeller KE, Keaton RM. Bipolar electrocoagulation for watermelon stomach. Gastrointest Endosc 1995; 42: 277–8.
Yousuff I, Brennan F, Ormonde D, Laurence B. Argon plasma coagulation for the treatment of watermelon stomach. Endoscopy 2002; 34: 407–10.
Mann NS, Rachut E. Gastric antral vascular ectasia causing severe hypoalbuminemia and anaemia cured by antrectomy. J Clin Gastroenterol 2002; 34: 284–6.
Rider JA, Klotz AP, Kirsner JB. Gastritis with veno capillary ectasia as a source of massive gastric haemorrhage. Gastroenterology 1953; 24: 118–23.
Bourke MJ, Hope RL, Boyd P, Gillespie PE, Cowen AE, Williams SJ. Endoscopic laser therapy for watermelon stomach. J Gastroenterol Hepatol 1996; 11: 832–4.
Chawla SK, Ramani K, Presti PL. The honeycomb stomach: Coalesced gastric angiodysplasia. Gastrointest Endosc 1990; 36: 516–8.
Stotzer P, Willen R, Kilander AF. Watermelon stomach: not only an antral disease. Gastrointest Endoscop 2002; 55: 897–900.
Shaffer RA, Scobey MW. Ring around cardia: A watermelon stomach variant. Gastrointest Endosc 2003; 57: 280–2.
Burak KW, Lee SS, Beck PL, Tasse D, Bui B, Willems B, et al. Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome. Gut 2001; 49: 866–72.
Spahr L, Villeneuve JP, Dufresne MP, et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 1999; 44: 739–42.
Gardiner GW, Murray D, Prokipehuk EJ. Watermelon stomach, or antral gastritis. J Clin Pathol 1985; 38: 1317–8.
Gilliam JH, Geisinger KR, Wu WC, Weidner N, Richter JE. Endoscopic biopsy is diagnostic in gastric antral vascular ectasia. Digest Dis Sci 1989; 34: 885–8.
Elkayam O, Oumanski M, Yaron M, Caspi D. Watermelon stomach following and preceding systemic sclerosis. Semin Arthritis Rheum 2000; 30: 127–31.
Viiala CH, Kaye JM, Hurley, Kasha SP. Watermelon stomach arising in association with Addison’s disease. J Clin Gastroenterol 2001; 33: 173–4.
Suit P, Petras RE, Bauer TW, Petrini JL Jr. Gastric antral vascular ectasia. A historical and morphometric study of »the watermelon stomach.« Am J Surg Pathol 1987; 11: 558–61.
Charneau J, Petit R, Cales P, Dauver A, Boyer Y. Antral motility in patients with cirrhosis with or without gastric antral vascular ectasia. Gut 1995; 37: 488–92.
Lowes JR, Rode J. Neuroendocrine cell proliferations in gastric antral vascular ectasia. Gastroenterology 1989; 97: 207–12.
Ruhl GH, Schnabel R, Peisler Seidel D. Gastric antral vascular ectasia: a case report of a 10 year follow up with special consideration of histopathological aspects. Z Gastroenterol 1994; 32: 160–4.
Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmited viral infections. The retrovirus Epidemiology Donor study. N Engl J Med 1996; 334: 1685–90.
Chamberland M, Khabbaz RF. Emerging issues in blood safety. Infect Dis Clin North Am. 1998; 12: 217–29.
Calam J, Walker RJ. Antral vascular lesion, achlorhydria and chronic blood los: response to steroids. Dig Dis Sci 1980; 25: 236–9.
Tran A, Villeneuve JP, Bilodeau M, Willems B, Marleau D, Fenyves D, et al. Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with oestrogen-progesterone in cirrhotic patients: an open pilot study. Am J Gastroenterol 1999; 94: 2909–11.
Barbara G, De Giorgio R, Salvioli B, Stanghlellini V, Corinaldesi R. Unsuccessful octreotide treatment of the watermelon stomach. J Clin Gastroenterol 1998; 26: 345–6.
Cabral JE, Pontes JM, Toste M, Camacho E, Leitao, Freitas D, Monteiro JG. Watermelon stomach: treatment with a serotonin antagonist. Am J Gastroenterol 1991; 86: 927–8.
Liberski SM, McGarrity TJ, Hartle RJ, Varano V, Reynolds D. The watermelon stomach: long-term outcome in patients with NdYAG laser therapy. Gastrointest Endosc 1990; 36: 399–402.
Petrini JJ, Johnston J. Heater probe for antral vascular ectasia. Gastrointest Endosc 1989: 35: 324–8.
Sargeant IR, Loizou LA, Rampton D, Tulloch M, Bown SG. Laser ablation of upper gastrointestinal vascular ectasias. Long term results. Gut 1993; 34: 470–5.
Geller A, Gostout CJ, Balm RK. Development of hyperplastic polyps following laser therapy for watermelon stomach. Gastrointest Endosc 1996; 43: 54–6.
ASGE. The argon plasma coagulator. Gastrointest Endosc 2002; 55: 807–10.
Probst A, Scheubel R, Wanbeck M. Treatment of watermelon stomach (gastric antral vascular ectasia) by means of endoscopic argon plasma coagulation (APC): long-term outcome. Z Gastroenterol 2001; 39: 447–52.
Novitsky YW, Kercher KW, Czerniach DR, Czerniach DR, Litwin DE. Watermelon stomach: pathophysiology, diagnosis, and managment. J Gastrointest Surg. 2003; 7: 652–61.
Brandt LJ. Gastric antral vascular ectasia: Is there to be a consensus. Gastrointest Endosc 1996; 44: 355–6.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
